March 14 (Reuters) - New Tech Capital SA NTCP.WA :
* SAID ON MONDAY IT HAS SIGNED INVESTMENT DEAL WITH ADVANCED
DIAGNOSTIC EQUIPMENT (ADE)
* UNDER DEAL THE PARTIES AGREED TO EXECUTE INVESTMENT OF
RUNNING
SPV ABLE TO ACHIEVE GOAL OF IMPLEMENTATION OF PRODUCTION AND
COMMERCIALISATION OF MEDICAL PRODUCT FOR MEASUREMENT OF SUGAR
LEVELS IN THE BODY
* UNDER DEAL ADE TO ACQUIRE STAKE IN SPV'S INCREASED SHARE
CAPITAL
IN EXCHANGE FOR PATENTS
* SAID EXCHANGE IS SUBJECT TO THE REGISTRATION OF SAID
MEDICAL
PRODUCT BY THE OFFICE FOR REGISTRATION OF MEDICINAL PRODUCTS,
MEDICAL DEVICES AND BIOCIDAL PRODUCTS
* UNDER DEAL THE COMPANY IS OBLIGED TO ACQUIRE AND PROVIDE
THE SPV
WITH FUNDS FOR EXECUTION OF CLINICAL STUDIES AND LEADING TO THE
SAID REGISTRATION
* THE GOALS SET FOR THE COMPANY HAVE TO BE MET NO LATER THAN
WITHIN TWO MONTHS OF SIGNING OF THE DEAL
Source text for Eikon: urn:newsml:reuters.com:*:nEM4zxHNLa
Further company coverage: NTCP.WA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 769 66 00;))